In a catabolic state like severe emaciation, this fat gain is therapeutic, but in other contexts, it would be counterproductive for fat loss
Despite the fact that GLP-1 is produced by everyone, some people, such as those with type 2 diabetes, often associated with obesity, require additional dosing
But with a multi-ingredient compound like Lipo C, sometimes a bit of uncertainty creeps in
Eur Rev Med Pharmacol Sci 25:6773 Nelson T, Zhang LX, Guo H, Nacul L, Song X (2021) Brainstem abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: a scoping review and evaluation of magnetic resonance imaging findings
Is diarrhea during GLP-1 therapy a sign that the medication is working